From the Department of Anesthesia, Harvard Medical School.
Cardiac Anesthesia Division, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
Anesth Analg. 2020 Aug;131(2):631-639. doi: 10.1213/ANE.0000000000004741.
Although immunomodulatory effects of anesthetics have been increasingly recognized, their underlying molecular mechanisms are not completely understood. Toll-like receptors (TLRs) are one of the major receptors to recognize invading pathogens and danger signals from damaged host tissues to initiate immune responses. Among the TLR family, TLR2 and TLR4 recognize a wide range of ligands and are considered to be important players in perioperative pathophysiology. Based on our recent finding that volatile anesthetics modulate TLR4 function, we tested our hypothesis that they would also modulate TLR2 function.
The effect of anesthetics isoflurane, sevoflurane, propofol, and dexmedetomidine on TLR2 activation was examined by reporter assays. An anesthetic that affected the activation was subjected to in silico rigid docking simulation on TLR2. To test our prediction that sevoflurane and a TLR1/TLR2 ligand Pam3CSK4 would compete for the same pocket of TLR2, we performed Pam3CSK4 competitive binding assay to TLR2 using HEK cells stably transfected with TLR2 (HEK-TLR2) with or without sevoflurane. We examined the effect of different anesthetics on the functions of human neutrophils stimulated with TLR2 ligands. Kruskal-Wallis test and Mann-Whitney U test were used for statistical analysis.
We observed that the attenuation of TLR1/TLR2 activation was seen on sevoflurane exposure but not on isoflurane, propofol, or dexmedetomidine exposure. The attenuation of TLR2/TLR6 activation was not seen in any of the anesthetics tested. The rigid docking simulation predicted that sevoflurane and Pam3CSK4 bound to the same pocket of TLR1/TLR2 complex. The binding of Pam3CSK4 to HEK-TLR2 cells was impaired in the presence of sevoflurane, indicating that sevoflurane and Pam3CSK4 competed for the pocket, as predicted in silico. The stimulation of neutrophils with Pam3CSK4 induced L-selection shedding but did not affect phagocytosis and reactive oxygen species production. L-selectin shedding from neutrophils was attenuated only by sevoflurane, consistent with the result of our reporter assays.
We found that TLR1/TLR2 activation was attenuated by sevoflurane, but we found no evidence for attenuation by isoflurane, propofol, or dexmedetomidine at clinically relevant concentrations. Our structural analysis and competition assay supported that sevoflurane directly bound to TLR2 at the interphase of the TLR1/TLR2 complex. Sevoflurane attenuated neutrophil L-selectin shedding, an important step for neutrophil migration.
尽管人们越来越认识到麻醉剂的免疫调节作用,但它们的潜在分子机制尚不完全清楚。Toll 样受体 (TLR) 是识别入侵病原体和受损宿主组织中危险信号以启动免疫反应的主要受体之一。在 TLR 家族中,TLR2 和 TLR4 识别广泛的配体,被认为是围手术期病理生理学中的重要参与者。基于我们最近发现挥发性麻醉剂调节 TLR4 功能的发现,我们检验了这样一个假设,即它们也会调节 TLR2 功能。
通过报告基因检测评估麻醉剂异氟醚、七氟醚、异丙酚和右美托咪定对 TLR2 激活的影响。对激活产生影响的麻醉剂进行 TLR2 的计算机刚性对接模拟。为了验证我们的预测,即七氟醚和 TLR1/TLR2 配体 Pam3CSK4 会竞争 TLR2 的相同口袋,我们使用稳定转染 TLR2 的人胚肾细胞(HEK-TLR2)进行 Pam3CSK4 竞争性结合测定,无论是否存在七氟醚。我们检测了不同麻醉剂对 TLR2 配体刺激的人嗜中性粒细胞功能的影响。使用 Kruskal-Wallis 检验和 Mann-Whitney U 检验进行统计分析。
我们观察到 TLR1/TLR2 激活的抑制作用仅见于七氟醚暴露,而不是异氟醚、异丙酚或右美托咪定暴露。在测试的任何麻醉剂中均未观察到 TLR2/TLR6 激活的抑制作用。刚性对接模拟预测七氟醚和 Pam3CSK4 结合到 TLR1/TLR2 复合物的相同口袋。七氟醚存在时,Pam3CSK4 与 HEK-TLR2 细胞的结合受到损害,这表明七氟醚和 Pam3CSK4 如计算机模拟中预测的那样竞争口袋。用 Pam3CSK4 刺激嗜中性粒细胞诱导 L-选择素脱落,但不影响吞噬作用和活性氧物质的产生。仅七氟醚减弱嗜中性粒细胞的 L-选择素脱落,这与我们的报告基因检测结果一致。
我们发现 TLR1/TLR2 的激活被七氟醚抑制,但我们在临床相关浓度下未发现异氟醚、异丙酚或右美托咪定的抑制作用。我们的结构分析和竞争测定支持七氟醚直接与 TLR2 结合在 TLR1/TLR2 复合物的界面上。七氟醚抑制嗜中性粒细胞 L-选择素脱落,这是嗜中性粒细胞迁移的重要步骤。